![]() |
| IGF2BP3 IHC performed on a B-cell acute lymphoblastic leukemia (B-ALL) case; blasts are positive while normal hematopoietic cells are negative. Image Credit: Courtesy of the Rao Lab. |
Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead. Now, researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a single protein, IGF2BP3, that links these two processes together in leukemia cells. The protein shifts how cells break down sugar, favoring a fast but inefficient energy pathway, while also altering RNA modifications that help produce the proteins leukemia cells need to survive and multiply.
The discovery published in Cell Reports, positions IGF2BP3 as a “master switch” in leukemia, linking metabolism and RNA regulation, processes long thought to operate independently. Understanding this connection could pave the way for new therapies aimed at cutting off the energy and survival pathways that cancer cells depend on.

_MoreDetail-v3_x2_1080x720.jpg)

_MoreDetail-v3_x2_1746x982.jpg)

_MoreDetail-v3_x2_2552x1710.jpg)

.jpg)
.jpg)
_MoreDetail-v3_x2_1352x762.jpg)
.jpg)



